The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models

Sang Youb Han1, Jung Yeon Ghee2, Jin Joo Cha2

  • 1Department of Internal Medicine, Inje University, Ilsan-Paik Hospital, Goyang 10380, Republic of Korea.

Life (Basel, Switzerland)
|February 25, 2023
PubMed

Insights

V-set Ig domain-containing 4 (VSIG4) protein and mRNA expression increased in mouse models of kidney injury. This suggests VSIG4 may play a role in the progression of chronic kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • V-set Ig domain-containing 4 (VSIG4) is known to regulate inflammatory responses and is implicated in various diseases.
  • The specific role of VSIG4 in the context of kidney diseases remains largely unexplored.

Purpose of the Study:

  • To investigate the expression and potential role of VSIG4 in different models of kidney injury.
  • To determine if VSIG4 is upregulated in response to kidney damage and if it correlates with disease markers.

Main Methods:

  • Utilized unilateral ureteral obstruction (UUO) and doxorubicin-induced kidney injury mouse models.
  • Examined VSIG4 mRNA and protein expression in kidney tissues and urinary samples.
  • Assessed VSIG4 levels in cultured podocytes subjected to doxorubicin treatment.
  • Correlated urinary VSIG4 levels with urinary albumin levels.

Main Results:

  • Urinary VSIG4 protein levels were significantly elevated in UUO mice compared to controls.
  • Both mRNA and protein expression of VSIG4 were upregulated in the kidneys of UUO mice.
  • In doxorubicin-induced kidney injury, urinary VSIG4 and albumin levels were significantly increased.
  • A strong positive correlation was found between urinary VSIG4 and albumin levels (r = 0.912, p < 0.001).
  • Intrarenal VSIG4 expression and podocyte VSIG4 expression were upregulated following doxorubicin treatment.

Conclusions:

  • VSIG4 expression is upregulated in both UUO and doxorubicin-induced kidney injury models.
  • These findings suggest that VSIG4 may be involved in the pathogenesis and progression of chronic kidney disease.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
56
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
52
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
41
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
49
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
49
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
36